⌘K

Login Start Free

Home/Filings/4/0001214659-21-010654

4//SEC Filing

Xie Yili Kevin 4

Accession 0001214659-21-010654

CIK 0001293310other

View on SEC.gov Company Profile

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 5:59 PM ET

Size

5.4 KB

Accession

0001214659-21-010654

Insider Transaction Report

Form 4

Period: 2021-10-19

HUMANIGEN, INCHGEN

Director

Transactions

Award
Stock Option (Right to Buy)
2021-10-19+42,866→ 42,866 total
Exercise: $6.56From: 2022-03-31Exp: 2031-10-18→ Common Stock (42,866 underlying)

Footnotes (1)

[F1]The option vests in 12 ratable quarterly installments commencing March 31, 2022.

Documents

1 file

4
marketforms-54036.xmlPrimary
PRIMARY DOCUMENT

Issuer

HUMANIGEN, INC

CIK 0001293310

Entity typeother

Related Parties

1

filerCIK 0001793506

Filing Metadata

Form type: 4
Filed: Oct 19, 8:00 PM ET
Accepted: Oct 20, 5:59 PM ET
Size: 5.4 KB

View on SEC.gov